FORA Capital LLC Increases Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)

FORA Capital LLC raised its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 34.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,569 shares of the medical research company’s stock after buying an additional 400 shares during […]

Related Keywords

Canada ,Washington ,United States ,Timothys Ernst , ,Royal Bank ,Credit Suisse Group ,Bio Rad Laboratories Company Profile ,Fora Capital ,Life Sciences ,Atlas Capital Advisors ,Securities Exchange Commission ,Belpointe Asset Management ,Bio Rad Laboratories Inc ,Group Ltd ,Bio Rad Laboratories ,Get Rating ,Capital Advisors ,Suisse Group ,Rad Laboratories Trading Down ,Rad Laboratories ,Clinical Diagnostics ,Life Science ,Bio Rad Laboratories Daily ,Nyse Bio ,Bio ,Medical ,09057220 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,